(MedPage Today) -- Daily consumption of enriched skim milk powder could help prevent gout flares, a proof-of-concept study suggested.

(MedPage Today) -- Muscle relaxants and neuromodulators offered little pain relief for rheumatoid arthritis patients and cannot currently be recommended, according to two Cochrane reviews.

(MedPage Today) -- During the past three decades there has been a dramatic increase in knee replacement surgeries, particularly among individuals in their 50s, a Finnish study found.

(MedPage Today) -- A rare inherited disorder known as cold urticaria results from a gain-of-function mutation in an immune system component that explains the condition's bizarre web of symptoms, researchers said.

(MedPage Today) -- Targeting an inflammatory cytokine can reduce gout flares after starting urate-lowering therapy, researchers found in an early trial.

(MedPage Today) -- Patients with rheumatoid arthritis are at increased risk of venous thromboembolism in addition to their well recognized risk for cardiovascular disease, a cohort study found.

(MedPage Today) -- Daily aspirin use may protect the heart but hurt the eyes, boosting the risk of age-related macular degeneration, researchers found.

Diuretics (MedPage Today) -- a class of drugs known to raise serum urate levels -- independently increased the risk for gout in patients with high blood pressure, a prospective cohort study revealed.

(MedPage Today) -- Atorvastatin did not slow atherosclerosis in children with systemic lupus erythematosus (SLE), according to the results of a multicenter, randomized trial.

(MedPage Today) -- Treatment with tumor nectosis factor inhibitors did not decrease the risk of acute coronary syndrome in patients with rheumatoid arthritis, even among patients who responded well to treatment, Swedish researchers found.

(MedPage Today) -- As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here's what has happened with the bone morphogenetic protein-2 saga (BMP-2) since last May when we published an article about a critical review of the product.